A soluble tumor necrosis factor receptor mutant

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/715 (2006.01) A61K 38/19 (2006.01) A61P 19/02 (2006.01) A61P 37/02 (2006.01) C07K 19/00 (2006.01) C12N 15/12 (2006.01) C12N 15/62 (2006.01)

Patent

CA 2710040

A soluble tumor necrosis factor receptor 2 (TNFRII) mutant has an amino acid substitution at position 92Glu compared with the wild TNFRII. The mutant improves the cytotoxicity capacity of neutralizing TNFalpha and lymphotoxin. The mutant and fusion protein comprising it are useful for the treatment of TNFalpha and lymphotoxin related diseases.

Un récepteur 2 de facteur de nécrose tumorale (TNFR2) mutant et soluble présente une substitution d'acide aminé à la position 92 Glu par rapport au TNFRII de type sauvage. La mutation augmente l'effet cytotoxique des TNF-alpha et TNF-beta. La mutation et la protéine de fusion en découlant peuvent être utilisées dans le traitement des maladies liées aux TNF-alpha et TNF-beta.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A soluble tumor necrosis factor receptor mutant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A soluble tumor necrosis factor receptor mutant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A soluble tumor necrosis factor receptor mutant will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1987818

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.